Imrecoxib attenuates bleomycin-induced pulmonary fibrosis in mice

Idiopathic pulmonary fibrosis (IPF) is an incurable chronic progressive disease with a low survival rate and ineffective therapeutic options. We examined the effects of imrecoxib, a nonsteroidal anti-inflammatory drug, on experimental pulmonary fibrosis. The mouse IPF model was established by intrat...

Descripción completa

Detalles Bibliográficos
Autores principales: Miao, Yang, Yang, Yue, Li, Xiaohe, Meng, Lingxin, Mao, Jiahe, Zhang, Jianwei, Gao, Jingjing, Yang, Cheng, Gu, Xiaoting, Zhou, Honggang, Zhang, Yanping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10663740/
https://www.ncbi.nlm.nih.gov/pubmed/38027732
http://dx.doi.org/10.1016/j.heliyon.2023.e20914

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10663740/
https://www.ncbi.nlm.nih.gov/pubmed/38027732
http://dx.doi.org/10.1016/j.heliyon.2023.e20914

Ejemplares similares